500-Person study investigates who says yes to Weight-Loss meds
NCT ID NCT07414043
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 500 people who are offered prescription weight-loss drugs like Wegovy or Mounjaro. Researchers want to understand what makes someone accept or refuse these medications. They will also track those who start treatment for up to 5 years to see how well the drugs work in real life and if people stick with them.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITINGBologna, Bologna, 40138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fiber gummies: a tasty new weapon against obesity?
- Can a diabetes drug improve joint replacement outcomes?
- Can a new pill help older adults lose weight without losing strength?
- Can one avocado a day sharpen the aging brain?
- Can a strict diet put type 2 diabetes into remission?
- Can Weight-Loss surgery alter how medications work?